Jun Li

High efficacy of azacitidine combined with homoharringtonine, idarubicin, and cytarabine in newly diagnosed patients with AML: A single arm, phase 2 trial

Z. Ge, Chunhua Song, Yan Huang, 2022, Frontiers in Oncology.

Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling

Z. Ge, Chunhua Song, H. Long, 2023, International journal of molecular sciences.